Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review | Lung Cancer | JAMA | JAMA Network

This narrative review summarizes advances in molecular testing for mutations in non–small cell lung cancer, selection of molecularly targeted therapies based on those mutations, and the use of PD-1 inhibitor immunotherapies for the management of metastatic and stage III nonmetastatic disease.

Source: Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review | Lung Cancer | JAMA | JAMA Network